Literature DB >> 15607208

A novel thymidine phosphorylase mutation in a Spanish MNGIE patient.

Josep Gamez1, Maria Carmen Lara, Fermin Mearin, Carlos Oliveras-Ley, Nuria Raguer, Montse Olive, Andres T Leist, Antonia Perello, Monica Perona, Carlos Cervera, Antonio Luis Andreu, Ramon Martí, Michio Hirano.   

Abstract

A 29-year-old Spanish man presented with chronic intestinal pseudo-obstruction, progressive external ophthalmoplegia, peripheral neuropathy, and diffuse leukoencephalopathy. This combination of clinical features is characteristic of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Genetic analysis revealed a novel 18-base pair (bp) duplication (5044-5061 dup) in exon 8 of the thymidine phosphorylase (TP) gene. The mutation is predicted to produce a 6 amino acid insertion in the alpha-beta-domain of the protein. This 18-bp insertion in the thymidine phosphorylase gene is the first duplication mutation identified in MNGIE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15607208     DOI: 10.1016/j.jns.2004.09.034

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE.

Authors:  J Torres-Torronteras; A Gómez; H Eixarch; L Palenzuela; G Pizzorno; M Hirano; A L Andreu; J Barquinero; R Martí
Journal:  Gene Ther       Date:  2011-03-31       Impact factor: 5.250

2.  Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features.

Authors:  W M M Schüpbach; K Madhavi Vadday; A Schaller; C Brekenfeld; L Kappeler; J F Benoist; C Nguyen-Thi Xuan-Huong; J M Burgunder; F Seibold; S Gallati; H P Mattle
Journal:  J Neurol       Date:  2007-02-09       Impact factor: 4.849

Review 3.  Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.

Authors:  Rana Yadak; Peter Sillevis Smitt; Marike W van Gisbergen; Niek P van Til; Irenaeus F M de Coo
Journal:  Front Cell Neurosci       Date:  2017-02-15       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.